Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …
In a research report issued Thursday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), while …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) shares are sinking nearly 40% pre-market on robust volume in response to a negative advisory committee vote for …
In a note issued short while ago, Aegis analyst Difei Yang dropped coverage of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI). Her previous Hold rating and price …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) received final approval from the FDA for the Company’s abbreviated new drug application for metformin hydrochloride extended release …
In a research note released Friday, Aegis analyst Difei Yang reiterated coverage on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) with a Buy rating and …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) announced that the FDA has accepted for filing the Company’s previously-announced New Drug Application (NDA) seeking authorization to …
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) announced that its United States (“U.S.
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) announced that U.S.
In a research report issued Friday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ :IPCI), …
